Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for IKZF1
Z-value: 1.93
Motif logo
Transcription factors associated with IKZF1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
IKZF1
|
ENSG00000185811.19 | IKZF1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| IKZF1 | hg38_v1_chr7_+_50304693_50304782 | 0.44 | 1.5e-02 | Click! |
Activity profile of IKZF1 motif
Sorted Z-values of IKZF1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of IKZF1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.4 | 38.3 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 2.5 | 7.5 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 2.4 | 7.2 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 2.4 | 9.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 2.3 | 7.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 2.3 | 9.2 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 2.2 | 6.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 2.1 | 12.7 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 2.1 | 6.2 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 2.0 | 7.8 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.9 | 9.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.8 | 5.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 1.7 | 5.0 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 1.6 | 4.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.6 | 4.8 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 1.5 | 13.9 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 1.5 | 4.4 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 1.5 | 4.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 1.4 | 1.4 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 1.4 | 5.6 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 1.4 | 5.5 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 1.4 | 4.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 1.3 | 5.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 1.3 | 3.8 | GO:0001300 | chronological cell aging(GO:0001300) |
| 1.3 | 7.7 | GO:0060356 | leucine import(GO:0060356) |
| 1.2 | 3.7 | GO:0098736 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 1.1 | 21.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.1 | 3.3 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 1.1 | 4.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 1.1 | 4.4 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 1.1 | 3.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 1.1 | 3.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 1.1 | 11.8 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 1.1 | 12.8 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 1.0 | 1.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 1.0 | 3.1 | GO:0060032 | notochord regression(GO:0060032) |
| 1.0 | 2.0 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 1.0 | 5.0 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 1.0 | 1.0 | GO:0018963 | phthalate metabolic process(GO:0018963) |
| 1.0 | 3.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 1.0 | 3.0 | GO:0006113 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 1.0 | 3.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 1.0 | 3.0 | GO:0070512 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 1.0 | 2.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 1.0 | 5.9 | GO:0035803 | egg coat formation(GO:0035803) |
| 1.0 | 14.7 | GO:0009629 | response to gravity(GO:0009629) |
| 1.0 | 2.9 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
| 1.0 | 7.6 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.9 | 6.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.9 | 2.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.9 | 0.9 | GO:0032425 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
| 0.9 | 3.7 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.9 | 0.9 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.9 | 12.0 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.9 | 12.8 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.9 | 6.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.9 | 3.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.9 | 3.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.9 | 4.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.9 | 2.6 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.8 | 3.4 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.8 | 5.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.8 | 16.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.8 | 1.6 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.8 | 2.4 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.8 | 0.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.8 | 6.4 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.8 | 3.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.8 | 2.3 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
| 0.8 | 0.8 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 0.8 | 2.3 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
| 0.8 | 4.6 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.8 | 2.3 | GO:1904170 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 0.8 | 3.0 | GO:1990834 | response to odorant(GO:1990834) |
| 0.8 | 4.5 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.8 | 4.5 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.7 | 1.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.7 | 3.0 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.7 | 3.0 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.7 | 9.7 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.7 | 2.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.7 | 20.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.7 | 2.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.7 | 2.9 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.7 | 6.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.7 | 3.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.7 | 2.1 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.7 | 4.2 | GO:0031337 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.7 | 2.8 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.7 | 5.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.7 | 2.8 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
| 0.7 | 16.7 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.7 | 4.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.7 | 3.5 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.7 | 2.8 | GO:0003290 | atrial septum secundum morphogenesis(GO:0003290) |
| 0.7 | 2.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.7 | 6.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.7 | 4.8 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 0.7 | 2.0 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.7 | 4.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.7 | 2.7 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.7 | 2.0 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 0.7 | 1.3 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.7 | 1.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.7 | 18.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.7 | 5.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.6 | 5.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.6 | 1.9 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.6 | 1.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.6 | 0.6 | GO:0044062 | regulation of excretion(GO:0044062) |
| 0.6 | 0.6 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.6 | 1.9 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.6 | 1.9 | GO:0033967 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.6 | 3.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.6 | 3.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.6 | 5.0 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.6 | 2.5 | GO:0038190 | vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.6 | 6.9 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.6 | 11.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.6 | 1.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.6 | 2.5 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.6 | 1.8 | GO:0060516 | primary prostatic bud elongation(GO:0060516) |
| 0.6 | 8.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.6 | 1.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.6 | 1.8 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.6 | 1.8 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.6 | 1.2 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
| 0.6 | 1.8 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.6 | 5.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.6 | 10.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.6 | 6.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.6 | 1.8 | GO:0044007 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
| 0.6 | 3.6 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.6 | 2.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.6 | 1.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.6 | 0.6 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus morphogenesis(GO:0072102) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.6 | 2.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.6 | 4.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.6 | 1.7 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.6 | 1.7 | GO:0014028 | notochord formation(GO:0014028) |
| 0.6 | 2.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.6 | 1.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.6 | 2.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.6 | 1.7 | GO:1905204 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.6 | 1.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.6 | 2.2 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.6 | 3.9 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.6 | 0.6 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
| 0.6 | 2.8 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.6 | 2.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.5 | 3.3 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.5 | 0.5 | GO:2000724 | positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.5 | 2.2 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.5 | 1.6 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.5 | 0.5 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.5 | 0.5 | GO:0010041 | response to iron(III) ion(GO:0010041) |
| 0.5 | 9.2 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.5 | 2.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.5 | 4.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.5 | 1.1 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.5 | 0.5 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
| 0.5 | 0.5 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
| 0.5 | 0.5 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 0.5 | 0.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.5 | 3.1 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.5 | 8.4 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.5 | 8.2 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
| 0.5 | 0.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.5 | 2.0 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.5 | 6.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.5 | 0.5 | GO:0071029 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) CUT catabolic process(GO:0071034) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) CUT metabolic process(GO:0071043) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.5 | 1.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.5 | 0.5 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.5 | 0.5 | GO:0097017 | renal protein absorption(GO:0097017) |
| 0.5 | 6.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 | 6.9 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.5 | 1.0 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.5 | 2.0 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.5 | 1.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.5 | 1.9 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.5 | 4.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.5 | 12.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.5 | 3.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.5 | 1.4 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.5 | 1.4 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.5 | 4.3 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.5 | 2.9 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 0.5 | 1.4 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.5 | 1.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.5 | 2.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.5 | 1.9 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.5 | 0.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.5 | 1.4 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.5 | 1.4 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.5 | 1.4 | GO:1904640 | response to methionine(GO:1904640) |
| 0.5 | 0.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.5 | 0.9 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.5 | 3.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.5 | 2.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.5 | 0.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.5 | 2.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.5 | 3.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.5 | 1.8 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.5 | 4.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.5 | 5.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 | 0.5 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.4 | 0.9 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.4 | 0.9 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.4 | 1.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.4 | 6.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.4 | 2.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.4 | 1.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.4 | 1.8 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.4 | 1.3 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.4 | 2.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.4 | 0.4 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.4 | 2.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.4 | 2.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.4 | 1.3 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.4 | 2.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.4 | 1.7 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.4 | 1.3 | GO:1903576 | response to L-arginine(GO:1903576) |
| 0.4 | 2.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.4 | 1.3 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.4 | 2.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.4 | 0.8 | GO:1904177 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.4 | 2.5 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.4 | 1.3 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.4 | 5.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.4 | 2.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.4 | 1.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.4 | 4.6 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.4 | 3.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.4 | 1.7 | GO:0042335 | cuticle development(GO:0042335) |
| 0.4 | 1.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.4 | 4.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.4 | 2.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 | 2.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.4 | 1.2 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.4 | 0.8 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.4 | 1.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.4 | 1.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.4 | 2.0 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.4 | 1.2 | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.4 | 1.6 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.4 | 2.8 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.4 | 0.4 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
| 0.4 | 2.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.4 | 1.6 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.4 | 1.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.4 | 2.4 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.4 | 3.6 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.4 | 3.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.4 | 4.0 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.4 | 2.4 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.4 | 1.2 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.4 | 4.3 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.4 | 50.4 | GO:0070268 | cornification(GO:0070268) |
| 0.4 | 5.9 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
| 0.4 | 0.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.4 | 7.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.4 | 1.2 | GO:0070316 | regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
| 0.4 | 2.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.4 | 0.4 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.4 | 0.4 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.4 | 5.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.4 | 0.8 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.4 | 0.4 | GO:0043931 | ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) bone maturation(GO:0070977) |
| 0.4 | 1.9 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.4 | 1.9 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.4 | 1.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.4 | 1.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.4 | 2.7 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
| 0.4 | 1.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.4 | 1.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.4 | 1.5 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.4 | 3.0 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.4 | 2.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.4 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.4 | 1.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.4 | 3.7 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.4 | 4.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.4 | 0.7 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.4 | 0.7 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.4 | 1.1 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.4 | 0.7 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.4 | 5.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.4 | 2.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.4 | 1.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.4 | 7.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.4 | 1.1 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.4 | 0.7 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.4 | 1.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.4 | 1.1 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.4 | 2.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.4 | 5.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.4 | 2.5 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.4 | 2.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.4 | 1.1 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.4 | 0.7 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 0.4 | 1.8 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.4 | 5.7 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.4 | 0.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.4 | 3.9 | GO:1902661 | positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.4 | 0.4 | GO:1902946 | protein localization to early endosome(GO:1902946) |
| 0.4 | 2.8 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.4 | 0.7 | GO:0009631 | cold acclimation(GO:0009631) |
| 0.4 | 3.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.4 | 2.8 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.4 | 1.8 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.4 | 1.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.4 | 1.1 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.4 | 3.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.4 | 1.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.4 | 1.1 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.3 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.3 | 3.1 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.3 | 2.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 10.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.3 | 1.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.3 | 8.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 2.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 | 0.3 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
| 0.3 | 1.0 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.3 | 1.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.3 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.3 | 1.0 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.3 | 0.7 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.3 | 4.4 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
| 0.3 | 1.0 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.3 | 0.7 | GO:0001806 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
| 0.3 | 1.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.3 | 0.7 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.3 | 1.0 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.3 | 2.4 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.3 | 4.0 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.3 | 1.3 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.3 | 1.3 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.3 | 3.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.3 | 2.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.3 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.3 | 0.7 | GO:0016103 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
| 0.3 | 2.3 | GO:0030421 | defecation(GO:0030421) |
| 0.3 | 1.3 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.3 | 2.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.3 | 1.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 | 2.3 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.3 | 0.3 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.3 | 3.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.3 | 1.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.3 | 1.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.3 | 0.6 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.3 | 0.6 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.3 | 3.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.3 | 0.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
| 0.3 | 0.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 | 0.6 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.3 | 1.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.3 | 0.3 | GO:2000360 | regulation of binding of sperm to zona pellucida(GO:2000359) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.3 | 0.9 | GO:0006227 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
| 0.3 | 0.6 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.3 | 12.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.3 | 1.6 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.3 | 0.9 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.3 | 1.9 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 0.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.3 | 2.2 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.3 | 0.6 | GO:0002581 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.3 | 4.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.3 | 0.9 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.3 | 0.9 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.3 | 1.5 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.3 | 0.9 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.3 | 1.5 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.3 | 0.6 | GO:0098583 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
| 0.3 | 1.5 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.3 | 0.9 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.3 | 0.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.3 | 1.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.3 | 0.6 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.3 | 0.6 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.3 | 0.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.3 | 2.1 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.3 | 1.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 | 2.1 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.3 | 0.9 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.3 | 3.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.3 | 3.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.3 | 0.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.3 | 4.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.3 | 0.6 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.3 | 0.9 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.3 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.3 | 2.0 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.3 | 0.6 | GO:2001186 | negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 0.3 | 0.6 | GO:1903365 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
| 0.3 | 1.4 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.3 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.3 | 1.1 | GO:0090294 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.3 | 3.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.3 | 1.1 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 0.3 | 2.8 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.3 | 1.7 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.3 | 2.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.3 | 0.8 | GO:0007343 | egg activation(GO:0007343) |
| 0.3 | 29.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.3 | 1.7 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 | 1.7 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.3 | 0.8 | GO:0071317 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.3 | 1.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.3 | 1.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.3 | 1.1 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.3 | 1.7 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.3 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.3 | 0.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.3 | 0.8 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 | 2.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.3 | 0.3 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.3 | 3.3 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.3 | 0.8 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.3 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.3 | 11.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.3 | 0.5 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
| 0.3 | 2.4 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.3 | 1.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.3 | 1.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.3 | 0.3 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 0.3 | 1.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 | 1.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.3 | 3.2 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.3 | 0.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.3 | 2.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.3 | 1.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.3 | 2.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.3 | 0.3 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.3 | 1.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.3 | 0.5 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.3 | 4.5 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
| 0.3 | 1.0 | GO:0030070 | insulin processing(GO:0030070) |
| 0.3 | 1.0 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.3 | 0.8 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.3 | 1.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.3 | 1.8 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.3 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 | 0.8 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.3 | 1.0 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.3 | 1.0 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.3 | 1.0 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.3 | 1.3 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
| 0.3 | 2.3 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.3 | 0.8 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.3 | 1.8 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.3 | 1.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.3 | 0.8 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.3 | 0.5 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
| 0.3 | 0.3 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.3 | 0.3 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.3 | 1.3 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.3 | 7.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.3 | 0.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.3 | 0.8 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.3 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.3 | 0.5 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.3 | 2.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.3 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.3 | 0.8 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.2 | 0.5 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
| 0.2 | 1.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.2 | 3.2 | GO:0030903 | notochord development(GO:0030903) |
| 0.2 | 1.0 | GO:0030047 | actin modification(GO:0030047) |
| 0.2 | 0.2 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.2 | 9.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.2 | 0.7 | GO:0018194 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 | 1.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.2 | 2.5 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 | 0.7 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.2 | 1.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.2 | 0.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.2 | 2.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.2 | 1.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 | 3.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 | 0.7 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 | 11.5 | GO:0097435 | fibril organization(GO:0097435) |
| 0.2 | 3.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.2 | 1.2 | GO:0031620 | regulation of fever generation(GO:0031620) |
| 0.2 | 2.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 | 0.7 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
| 0.2 | 1.0 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.2 | 0.5 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.2 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.2 | 0.7 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.2 | 1.0 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.2 | 1.0 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 | 0.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 | 0.7 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.2 | 0.7 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.2 | 0.9 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.2 | 0.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 | 0.9 | GO:0010193 | response to ozone(GO:0010193) |
| 0.2 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 | 1.2 | GO:0015862 | uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.2 | 5.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.2 | 3.5 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.2 | 9.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.2 | 2.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.2 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.2 | 2.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.2 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 | 1.2 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 | 0.5 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.2 | 2.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 | 0.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.2 | 0.9 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.2 | 0.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 | 2.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.2 | 0.5 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.2 | 1.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 | 1.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.2 | 0.7 | GO:0050904 | diapedesis(GO:0050904) |
| 0.2 | 0.9 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.2 | 4.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.2 | 1.4 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.2 | 2.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.2 | 1.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.2 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
| 0.2 | 0.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.2 | 0.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.2 | 1.1 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.2 | 1.1 | GO:2000852 | regulation of corticosterone secretion(GO:2000852) |
| 0.2 | 0.7 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.2 | 0.7 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.2 | 2.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.2 | 3.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 | 0.5 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.2 | 1.8 | GO:0042262 | DNA protection(GO:0042262) |
| 0.2 | 0.9 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.2 | 0.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.2 | 0.7 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 0.2 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 | 1.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.2 | 1.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.2 | 0.4 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.2 | 0.2 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.2 | 8.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.2 | 0.4 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.2 | 0.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 | 0.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 | 0.7 | GO:0048627 | myoblast development(GO:0048627) |
| 0.2 | 0.7 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 0.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 0.4 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 | 0.9 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.2 | 0.7 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.2 | 3.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 | 4.3 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.2 | 1.7 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.2 | 1.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 2.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.2 | 2.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.2 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.2 | 0.2 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.2 | 1.3 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 | 0.4 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.2 | 1.9 | GO:0003360 | brainstem development(GO:0003360) |
| 0.2 | 3.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.2 | 0.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.2 | 2.3 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.2 | 0.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.2 | 0.8 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.2 | 0.4 | GO:0021548 | pons development(GO:0021548) |
| 0.2 | 0.6 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.2 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 | 0.8 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.2 | 0.6 | GO:1901656 | glucoside transport(GO:0042946) glycoside transport(GO:1901656) |
| 0.2 | 1.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 | 1.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.2 | 0.6 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.2 | 1.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.2 | 0.6 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 0.2 | 1.2 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 | 0.6 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.2 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.2 | 1.6 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.2 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.2 | 3.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.2 | 2.9 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.2 | 0.6 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.2 | 1.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.2 | 1.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 | 0.6 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.2 | 0.4 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
| 0.2 | 1.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.2 | 1.4 | GO:0060068 | vagina development(GO:0060068) |
| 0.2 | 1.0 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.2 | 3.8 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.2 | 0.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 2.4 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.2 | 1.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) quinolinate metabolic process(GO:0046874) |
| 0.2 | 0.6 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.2 | 0.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.2 | 0.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.2 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 | 0.4 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.2 | 1.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.2 | 2.0 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
| 0.2 | 2.0 | GO:0051383 | kinetochore organization(GO:0051383) |
| 0.2 | 0.6 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 | 0.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 0.2 | 0.6 | GO:0046080 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.2 | 1.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.2 | 0.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 1.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 0.6 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.2 | 0.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.2 | 0.6 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.2 | 15.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 | 1.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.2 | 1.2 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.2 | 0.2 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 0.2 | 2.1 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.2 | 0.4 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.2 | 1.9 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.2 | 1.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
| 0.2 | 1.0 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.2 | 0.2 | GO:0044266 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 | 1.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.2 | 0.8 | GO:0072185 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 | 0.6 | GO:0071400 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) cellular response to oleic acid(GO:0071400) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.2 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 | 0.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.2 | 0.8 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.2 | 1.1 | GO:0046697 | decidualization(GO:0046697) |
| 0.2 | 2.4 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.2 | 1.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.2 | 0.9 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.2 | 14.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.2 | 0.9 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.2 | 0.2 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.2 | 2.0 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.2 | 1.5 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 | 1.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.2 | 0.7 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.2 | 0.4 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.2 | 0.7 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.2 | 0.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.2 | 1.1 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.2 | 0.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.2 | 2.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.2 | 0.4 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
| 0.2 | 6.6 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.2 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 5.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.2 | 0.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 | 0.4 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.2 | 1.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 | 1.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 0.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
| 0.2 | 2.0 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.2 | 0.2 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.2 | 0.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.2 | 3.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 1.6 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.2 | 0.5 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.2 | 3.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.2 | 2.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 | 2.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.2 | 4.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.2 | 3.5 | GO:0033198 | response to ATP(GO:0033198) |
| 0.2 | 1.1 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.2 | 0.5 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 | 0.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.2 | 3.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.2 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.2 | 0.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.2 | 1.7 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 | 0.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.2 | 2.9 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.2 | 2.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.2 | 0.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 | 0.9 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.2 | 0.7 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.2 | 1.5 | GO:0010288 | response to lead ion(GO:0010288) |
| 0.2 | 0.3 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.2 | 2.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.2 | 0.7 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.2 | 1.5 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.2 | 2.9 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.2 | 0.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 | 0.2 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.2 | 0.8 | GO:0000050 | urea cycle(GO:0000050) |
| 0.2 | 0.2 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.2 | 0.2 | GO:0072172 | mesonephric tubule formation(GO:0072172) |
| 0.2 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.2 | 4.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 12.9 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.2 | 0.5 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.2 | 1.7 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.2 | 0.3 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.2 | 0.8 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.2 | 0.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.2 | 0.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.2 | 1.5 | GO:0090493 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.2 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.2 | 0.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.2 | 0.7 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.2 | 0.5 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.2 | 7.9 | GO:1901998 | toxin transport(GO:1901998) |
| 0.2 | 2.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.2 | 0.5 | GO:2000418 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.2 | 1.8 | GO:0045006 | DNA deamination(GO:0045006) |
| 0.2 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.2 | 1.1 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.2 | 0.6 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.2 | 0.5 | GO:1902462 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.2 | 3.9 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.2 | 1.3 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.2 | 0.5 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.2 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.2 | 0.8 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.2 | 0.3 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 | 9.8 | GO:0043486 | histone exchange(GO:0043486) |
| 0.2 | 1.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 0.3 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.2 | 0.6 | GO:0006569 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
| 0.2 | 1.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 3.6 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.2 | 0.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.2 | 1.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.2 | 0.5 | GO:0061163 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.2 | 0.2 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.2 | 1.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 | 0.2 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.2 | 1.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.2 | 1.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 | 0.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 | 2.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.2 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 | 0.6 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
| 0.2 | 3.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 1.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.2 | 1.8 | GO:0007135 | meiosis II(GO:0007135) |
| 0.2 | 0.6 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.2 | 0.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.2 | 0.6 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.2 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.2 | 1.2 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.2 | 1.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 | 1.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.2 | 0.5 | GO:1904328 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.2 | 0.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.2 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.2 | 0.6 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.2 | 3.2 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.2 | 0.6 | GO:0007512 | adult heart development(GO:0007512) |
| 0.2 | 3.6 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.2 | 0.5 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.2 | 0.6 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.2 | 0.2 | GO:0071362 | cellular response to ether(GO:0071362) |
| 0.2 | 0.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.2 | 0.5 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.2 | 0.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.2 | 1.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.1 | 1.5 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.1 | 0.7 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 | 0.9 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 0.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 | 0.4 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) |
| 0.1 | 0.4 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 0.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 | 1.5 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 | 2.6 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 | 1.9 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 2.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.1 | 2.0 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 0.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 0.3 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.1 | 0.9 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 | 0.4 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 1.0 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.1 | 2.1 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.1 | 0.3 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.1 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 1.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.6 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 0.4 | GO:0006534 | cysteine metabolic process(GO:0006534) |
| 0.1 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
| 0.1 | 0.4 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.1 | 4.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.1 | 1.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.1 | 3.5 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 | 0.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 | 0.6 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 | 0.4 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 | 2.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 1.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 0.7 | GO:0001759 | organ induction(GO:0001759) |
| 0.1 | 0.3 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 1.4 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 | 1.3 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
| 0.1 | 0.3 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.1 | 1.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 | 0.7 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 | 0.8 | GO:0046618 | drug export(GO:0046618) |
| 0.1 | 0.4 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.1 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.1 | 0.5 | GO:0044107 | cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
| 0.1 | 0.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 | 0.4 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 | 0.5 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.1 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 0.1 | 0.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.1 | 2.8 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 | 0.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.1 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.1 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) positive regulation of long term synaptic depression(GO:1900454) |
| 0.1 | 2.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 2.1 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 | 0.5 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.1 | 0.9 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.1 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 | 0.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.1 | 3.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 2.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 1.1 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.1 | 0.7 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.1 | 0.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
| 0.1 | 0.3 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 0.6 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 | 0.6 | GO:0019557 | formate metabolic process(GO:0015942) histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.1 | 0.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.1 | 0.4 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.1 | 1.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.1 | 0.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 | 0.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 | 0.1 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.1 | 0.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 0.3 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.1 | 1.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.1 | 1.2 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.1 | 0.9 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.1 | 0.6 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.1 | 0.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.1 | 0.4 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
| 0.1 | 0.5 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 | 1.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 2.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 | 0.5 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 1.5 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 1.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 0.5 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.1 | 1.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 2.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 | 1.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
| 0.1 | 1.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 0.5 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 | 5.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 0.4 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.1 | 0.7 | GO:0060065 | uterus development(GO:0060065) |
| 0.1 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 | 0.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.1 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
| 0.1 | 0.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 | 0.1 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 | 16.0 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.1 | 0.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 1.6 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.1 | 0.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.1 | 3.0 | GO:0033762 | response to glucagon(GO:0033762) |
| 0.1 | 1.4 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 0.1 | 7.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 0.5 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.1 | 3.2 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.1 | 4.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 | 0.4 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.1 | 0.4 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
| 0.1 | 0.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.1 | 0.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 | 0.8 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.1 | 0.1 | GO:0030221 | basophil differentiation(GO:0030221) |
| 0.1 | 2.9 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 1.8 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
| 0.1 | 0.2 | GO:0098598 | learned vocalization behavior or vocal learning(GO:0098598) |
| 0.1 | 1.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
| 0.1 | 0.2 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 0.1 | 1.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 | 2.5 | GO:0001964 | startle response(GO:0001964) |
| 0.1 | 1.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.1 | 0.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 | 0.1 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 0.1 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.1 | 0.3 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 0.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.1 | 0.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.1 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.1 | 0.7 | GO:0072319 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 | 1.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 0.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 | 2.5 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.1 | 4.3 | GO:0001570 | vasculogenesis(GO:0001570) |
| 0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 | 0.4 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.1 | 1.7 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 0.8 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.1 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.1 | 0.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 0.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.1 | 0.5 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.1 | 0.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 | 0.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.1 | 0.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.1 | 1.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 0.3 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.1 | 0.2 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.1 | 1.5 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.1 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.1 | 0.5 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 | 0.1 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
| 0.1 | 0.2 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.1 | 1.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 | 0.4 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.1 | 0.5 | GO:0060613 | fat pad development(GO:0060613) |
| 0.1 | 0.5 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 | 3.7 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 0.1 | 0.3 | GO:0090656 | t-circle formation(GO:0090656) |
| 0.1 | 0.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 | 0.7 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 | 0.1 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.1 | 1.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 | 1.3 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.1 | 0.6 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.1 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.1 | 0.6 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 3.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.1 | 2.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 0.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 1.0 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 | 0.3 | GO:0070099 | response to cortisol(GO:0051414) regulation of chemokine-mediated signaling pathway(GO:0070099) |
| 0.1 | 0.4 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 0.5 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.1 | 0.9 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 | 1.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 0.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 | 1.1 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.1 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.1 | 0.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.1 | 0.2 | GO:0060932 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) His-Purkinje system cell differentiation(GO:0060932) |
| 0.1 | 0.3 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 0.8 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.1 | 1.0 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 | 1.8 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.1 | 0.3 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.1 | 0.4 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 1.0 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
| 0.1 | 0.3 | GO:0015847 | putrescine transport(GO:0015847) |
| 0.1 | 0.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 0.1 | 5.2 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
| 0.1 | 0.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 | 0.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 | 0.2 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
| 0.1 | 0.2 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.1 | 1.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.4 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 | 0.3 | GO:0045554 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.1 | 0.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.1 | 0.3 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.1 | 0.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 1.5 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 | 0.3 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 0.1 | 4.1 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.1 | 0.9 | GO:0030220 | platelet formation(GO:0030220) |
| 0.1 | 1.3 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.4 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 | 1.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 1.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 1.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 1.9 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.1 | 0.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 0.1 | 1.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.2 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 | 0.3 | GO:1902474 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 | 0.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.1 | 2.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 0.4 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.1 | 0.3 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
| 0.1 | 0.3 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.1 | 1.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
| 0.1 | 3.4 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.1 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 3.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.1 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.1 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
| 0.1 | 0.3 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
| 0.1 | 0.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 | 1.4 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.1 | 2.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.2 | GO:1903416 | response to glycoside(GO:1903416) |
| 0.1 | 0.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 | 0.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.4 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.1 | 0.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 | 0.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.1 | 0.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 | 2.6 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.1 | 4.6 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.1 | 0.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.1 | 0.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
| 0.1 | 0.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 1.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 0.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.1 | 0.2 | GO:0050976 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.1 | 1.8 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.1 | 0.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.1 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.3 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 | 0.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 0.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.1 | 0.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 0.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.1 | 0.1 | GO:0046051 | UTP metabolic process(GO:0046051) |
| 0.1 | 2.9 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.1 | 0.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.1 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
| 0.1 | 0.5 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.1 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 0.1 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.1 | 0.7 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
| 0.1 | 0.2 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.1 | 0.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
| 0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.1 | 0.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.1 | 1.5 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
| 0.1 | 2.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.1 | 1.9 | GO:0090278 | negative regulation of peptide hormone secretion(GO:0090278) |
| 0.1 | 3.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.1 | 0.3 | GO:0070378 | positive regulation of ERK5 cascade(GO:0070378) |
| 0.1 | 1.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 | 0.2 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.1 | 0.3 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 0.7 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.2 | GO:1900005 | positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.1 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 0.5 | GO:0045188 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.1 | 1.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 0.3 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.1 | 0.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 0.2 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.1 | 0.7 | GO:0032094 | response to food(GO:0032094) |
| 0.1 | 0.5 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.1 | 1.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.1 | 0.2 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.1 | 0.3 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 | 2.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.1 | 0.5 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
| 0.1 | 1.0 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.1 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
| 0.1 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.1 | 0.1 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.1 | 0.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 | 2.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.1 | 4.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 0.3 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 0.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.1 | 1.4 | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) |
| 0.1 | 0.6 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.1 | 0.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.8 | GO:0021983 | pituitary gland development(GO:0021983) |
| 0.1 | 3.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 1.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 | 0.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.1 | 0.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 0.4 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.1 | 0.7 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 | 0.4 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.1 | 0.3 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
| 0.1 | 0.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 0.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.8 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 | 0.6 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 | 0.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.3 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.1 | 0.8 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 1.6 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.1 | 0.1 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.1 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 8.5 | GO:0007565 | female pregnancy(GO:0007565) |
| 0.1 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.1 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 0.1 | 0.2 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.1 | 0.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 0.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.1 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 | 0.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 0.1 | GO:0070778 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.1 | 0.5 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 5.5 | GO:0051017 | actin filament bundle assembly(GO:0051017) |
| 0.1 | 0.5 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 3.1 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 | 1.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 | 1.2 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 0.3 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
| 0.1 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 | 0.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.1 | 0.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.1 | 0.2 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.1 | 0.3 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 0.1 | 0.2 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.1 | 0.6 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 | 1.3 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.1 | 0.6 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
| 0.1 | 0.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 3.7 | GO:0051592 | response to calcium ion(GO:0051592) |
| 0.1 | 0.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
| 0.1 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 0.1 | 0.1 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.1 | 0.1 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 1.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 2.0 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.5 | GO:0071545 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
| 0.1 | 0.2 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 | 0.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 0.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 0.1 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 | 0.5 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 | 3.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.2 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 1.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 0.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.1 | 9.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 | 0.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 0.6 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.1 | 0.1 | GO:0030647 | aminoglycoside antibiotic metabolic process(GO:0030647) |
| 0.1 | 2.0 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.1 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.1 | 0.3 | GO:0032196 | transposition(GO:0032196) |
| 0.1 | 0.2 | GO:0061582 | colon epithelial cell migration(GO:0061580) intestinal epithelial cell migration(GO:0061582) |
| 0.1 | 0.1 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
| 0.1 | 0.3 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 | 0.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
| 0.1 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.2 | GO:0051645 | Golgi localization(GO:0051645) |
| 0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.1 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 0.3 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.1 | 0.2 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.1 | 0.8 | GO:0060789 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) hair follicle placode formation(GO:0060789) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.0 | 0.1 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
| 0.0 | 0.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.0 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.7 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 1.0 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 | 0.1 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.0 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.0 | 0.3 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.0 | 0.2 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
| 0.0 | 0.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.0 | 0.7 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.0 | 0.1 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.0 | 0.0 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.0 | 0.4 | GO:0035510 | DNA dealkylation(GO:0035510) DNA demethylation(GO:0080111) |
| 0.0 | 1.4 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
| 0.0 | 0.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 0.0 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 | 0.1 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.0 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.0 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.0 | 0.8 | GO:0021766 | hippocampus development(GO:0021766) |
| 0.0 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.0 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.1 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.0 | 0.2 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.0 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.0 | 0.0 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 | 1.1 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 | 0.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 | 0.2 | GO:0006563 | L-serine metabolic process(GO:0006563) |
| 0.0 | 0.3 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.0 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
| 0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.0 | 0.1 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.0 | 0.1 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
| 0.0 | 0.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
| 0.0 | 0.2 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 | 0.7 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 | 0.1 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 0.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.0 | 0.9 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.0 | 0.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 | 0.3 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 | 0.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.0 | 0.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 | 0.6 | GO:0031018 | endocrine pancreas development(GO:0031018) |
| 0.0 | 0.1 | GO:0021604 | cranial nerve structural organization(GO:0021604) facial nerve structural organization(GO:0021612) |
| 0.0 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.0 | 0.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.0 | 0.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.0 | 0.2 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.0 | 0.5 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
| 0.0 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 | 2.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.0 | 0.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.0 | 0.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.4 | GO:0006555 | methionine metabolic process(GO:0006555) |
| 0.0 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 | 0.7 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
| 0.0 | 0.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 | 0.1 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 | 1.0 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
| 0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 | 0.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 | 0.3 | GO:0001832 | blastocyst growth(GO:0001832) |
| 0.0 | 0.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.0 | 0.7 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.0 | 0.8 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.0 | 3.1 | GO:0000819 | sister chromatid segregation(GO:0000819) |
| 0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.0 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.0 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.0 | 1.0 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 | 0.2 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.0 | 0.1 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.0 | 0.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.0 | 1.5 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.0 | 0.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 | 1.4 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 | 0.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
| 0.0 | 3.3 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.0 | 0.1 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
| 0.0 | 0.9 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 | 0.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.3 | GO:0032885 | regulation of polysaccharide biosynthetic process(GO:0032885) |
| 0.0 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
| 0.0 | 0.9 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.0 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.0 | 0.1 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.0 | 0.3 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 | 0.2 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.0 | 0.1 | GO:0046778 | modulation by virus of host gene expression(GO:0039656) modification by virus of host mRNA processing(GO:0046778) |
| 0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.0 | 0.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.0 | 0.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 | 0.0 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
| 0.0 | 0.4 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 0.1 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.0 | 0.4 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 0.1 | GO:0060509 | female courtship behavior(GO:0008050) Type I pneumocyte differentiation(GO:0060509) |
| 0.0 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.0 | 0.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 | 0.1 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
| 0.0 | 0.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.0 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.0 | 0.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 0.0 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 | 0.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
| 0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.0 | 0.1 | GO:0032532 | regulation of microvillus length(GO:0032532) intermicrovillar adhesion(GO:0090675) |
| 0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
| 0.0 | 0.3 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
| 0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
| 0.0 | 0.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.2 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 0.1 | GO:1903909 | regulation of receptor clustering(GO:1903909) |
| 0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.0 | 0.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.0 | 0.5 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
| 0.0 | 0.5 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 | 0.1 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.0 | 0.1 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
| 0.0 | 0.0 | GO:0050432 | catecholamine secretion(GO:0050432) |
| 0.0 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.0 | 0.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 2.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.0 | 0.1 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.0 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.0 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
| 0.0 | 0.1 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 | 0.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.0 | 0.2 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.0 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.0 | 0.1 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.2 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 | 1.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
| 0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.0 | 0.0 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 | 0.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 | 0.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 | 0.2 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
| 0.0 | 0.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 | 0.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 | 0.2 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 | 0.0 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
| 0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.0 | 0.1 | GO:0006775 | fat-soluble vitamin metabolic process(GO:0006775) |
| 0.0 | 0.0 | GO:0031649 | heat generation(GO:0031649) |
| 0.0 | 0.0 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 | 0.0 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.5 | 38.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 2.1 | 6.4 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 2.1 | 6.2 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 1.8 | 8.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 1.5 | 4.5 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 1.1 | 6.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 1.1 | 5.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 1.0 | 23.8 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 1.0 | 4.9 | GO:0031523 | Myb complex(GO:0031523) |
| 1.0 | 14.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 1.0 | 1.0 | GO:0051286 | cell tip(GO:0051286) |
| 0.9 | 3.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.9 | 3.6 | GO:0097229 | sperm end piece(GO:0097229) |
| 0.9 | 6.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.9 | 2.6 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.8 | 3.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.8 | 2.5 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.8 | 2.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.8 | 4.1 | GO:0032449 | CBM complex(GO:0032449) |
| 0.8 | 4.1 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.8 | 4.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.8 | 2.4 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.8 | 4.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.7 | 8.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.7 | 2.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.7 | 10.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.7 | 1.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 0.7 | 3.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.7 | 2.7 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.7 | 2.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.7 | 2.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.7 | 2.0 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.7 | 2.0 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.7 | 2.6 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.6 | 0.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.6 | 13.3 | GO:0005861 | troponin complex(GO:0005861) |
| 0.6 | 3.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.6 | 2.4 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.6 | 3.0 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.6 | 5.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.6 | 9.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.6 | 2.9 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.6 | 3.5 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.6 | 1.7 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
| 0.6 | 6.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.6 | 2.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.6 | 2.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.5 | 0.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.5 | 4.4 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.5 | 10.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.5 | 2.6 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.5 | 2.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.5 | 9.4 | GO:0008091 | spectrin(GO:0008091) |
| 0.5 | 1.5 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.5 | 2.0 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.5 | 29.0 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.5 | 2.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.5 | 3.8 | GO:0000796 | condensin complex(GO:0000796) |
| 0.5 | 8.1 | GO:0070938 | contractile ring(GO:0070938) |
| 0.5 | 1.4 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.5 | 12.3 | GO:0005922 | connexon complex(GO:0005922) |
| 0.5 | 7.5 | GO:0042555 | MCM complex(GO:0042555) |
| 0.5 | 4.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.4 | 2.2 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.4 | 10.8 | GO:0042627 | chylomicron(GO:0042627) |
| 0.4 | 3.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.4 | 6.5 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.4 | 0.8 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.4 | 9.4 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.4 | 0.4 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.4 | 5.5 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.4 | 3.9 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 0.4 | 4.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.4 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.4 | 1.6 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 0.4 | 3.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.4 | 1.9 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.4 | 3.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.4 | 3.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.4 | 1.1 | GO:0000805 | X chromosome(GO:0000805) |
| 0.4 | 2.6 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.4 | 2.6 | GO:0000801 | central element(GO:0000801) |
| 0.4 | 3.6 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.4 | 4.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.4 | 7.9 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.4 | 7.2 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.4 | 2.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.4 | 2.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.3 | 1.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.3 | 11.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.3 | 1.3 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.3 | 1.6 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.3 | 1.0 | GO:0071754 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 0.3 | 2.9 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.3 | 0.9 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.3 | 2.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.3 | 1.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.3 | 2.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.3 | 1.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.3 | 4.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.3 | 1.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.3 | 6.2 | GO:0043219 | lateral loop(GO:0043219) |
| 0.3 | 3.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.3 | 2.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.3 | 1.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.3 | 0.9 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.3 | 0.3 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.3 | 6.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.3 | 0.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.3 | 0.9 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.3 | 2.0 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.3 | 1.4 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.3 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.3 | 1.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.3 | 2.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 1.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.3 | 1.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.3 | 0.5 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.3 | 0.5 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.3 | 7.8 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.3 | 4.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.3 | 2.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.2 | 5.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.2 | 5.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 1.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.2 | 1.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.2 | 1.0 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.2 | 1.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.2 | 3.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.2 | 4.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.2 | 15.2 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.2 | 0.2 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.2 | 2.6 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.2 | 4.1 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.2 | 3.0 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.2 | 1.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.2 | 0.7 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
| 0.2 | 2.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 2.0 | GO:0071546 | pi-body(GO:0071546) |
| 0.2 | 2.5 | GO:0005638 | lamin filament(GO:0005638) |
| 0.2 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.2 | 3.8 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
| 0.2 | 1.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.2 | 5.0 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.2 | 2.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.2 | 0.4 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.2 | 1.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.2 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
| 0.2 | 2.1 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.2 | 0.8 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.2 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.2 | 0.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.2 | 2.2 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
| 0.2 | 1.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.2 | 0.8 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.2 | 1.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.2 | 3.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.2 | 1.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.2 | 1.9 | GO:0032059 | bleb(GO:0032059) |
| 0.2 | 1.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.2 | 3.1 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 2.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.2 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.2 | 18.3 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.2 | 1.3 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
| 0.2 | 0.7 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.2 | 2.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 1.6 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
| 0.2 | 7.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.2 | 3.5 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.2 | 0.5 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.2 | 8.2 | GO:0002102 | podosome(GO:0002102) |
| 0.2 | 1.0 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.2 | 0.5 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.2 | 0.7 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.2 | 0.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
| 0.2 | 8.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.2 | 2.7 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.2 | 5.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.2 | 0.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.2 | 0.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.2 | 1.0 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.2 | 0.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.2 | 13.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.2 | 1.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.2 | 2.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.2 | 0.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.2 | 2.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.2 | 4.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.2 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.2 | 1.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.2 | 2.3 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 3.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 1.8 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 0.5 | GO:1905103 | integral component of lysosomal membrane(GO:1905103) |
| 0.2 | 1.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.2 | 1.1 | GO:0033503 | HULC complex(GO:0033503) |
| 0.2 | 6.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.2 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 0.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.2 | 1.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.2 | 2.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.2 | 0.8 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.2 | 0.8 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.2 | 2.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 18.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 1.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.1 | 3.1 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 5.2 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 2.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 1.4 | GO:0070449 | elongin complex(GO:0070449) |
| 0.1 | 0.4 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.1 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 1.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.6 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.1 | 0.6 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.1 | 4.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.1 | 1.5 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.1 | 38.1 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 1.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.1 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.1 | 0.6 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.1 | 0.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.1 | 3.4 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 0.4 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.1 | 1.5 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.1 | 8.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 1.8 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 1.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 3.1 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 13.9 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 0.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 1.5 | GO:0071203 | WASH complex(GO:0071203) |
| 0.1 | 0.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.1 | 1.8 | GO:0045120 | pronucleus(GO:0045120) |
| 0.1 | 2.4 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 13.9 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 14.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 0.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 9.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
| 0.1 | 1.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 0.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 1.0 | GO:0033643 | host cell part(GO:0033643) |
| 0.1 | 3.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 0.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.1 | 18.0 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 57.2 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 1.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 2.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 0.5 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 0.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.1 | 1.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.1 | 1.9 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.1 | 0.5 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 2.1 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.3 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.1 | 2.7 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.1 | 0.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.1 | 1.8 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.1 | 0.6 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 0.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 4.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 1.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 5.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 2.9 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.1 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.1 | 1.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 5.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 1.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 1.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 2.4 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 2.3 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 0.1 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.1 | 0.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 0.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 1.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 0.7 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 1.1 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 0.4 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.1 | 7.2 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 3.2 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 1.1 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.1 | 0.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 8.1 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 0.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.1 | 4.3 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 0.4 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.1 | 5.1 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.1 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.1 | 0.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 0.3 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 2.8 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.1 | 0.2 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.1 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.1 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 21.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.1 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
| 0.1 | 16.3 | GO:0045121 | membrane raft(GO:0045121) |
| 0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.1 | 1.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 1.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 1.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 0.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 1.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 1.5 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.1 | 0.6 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 5.3 | GO:0030018 | Z disc(GO:0030018) |
| 0.1 | 0.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.1 | 6.3 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 0.5 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.1 | 0.6 | GO:0032797 | SMN complex(GO:0032797) |
| 0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.1 | 0.7 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.1 | 5.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 0.2 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.1 | 0.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 1.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
| 0.1 | 8.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.1 | 0.2 | GO:1990879 | CST complex(GO:1990879) |
| 0.1 | 0.2 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.1 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
| 0.1 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.1 | 0.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.1 | 4.8 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.0 | 0.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.0 | 0.4 | GO:0098644 | complex of collagen trimers(GO:0098644) |
| 0.0 | 2.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.0 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.0 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.0 | 0.8 | GO:0030016 | myofibril(GO:0030016) |
| 0.0 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 0.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.0 | 3.2 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 3.9 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.0 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.0 | 0.3 | GO:0034448 | EGO complex(GO:0034448) |
| 0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.0 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.0 | 0.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.0 | 6.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 2.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.0 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.0 | 1.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.0 | 0.6 | GO:1990752 | microtubule end(GO:1990752) |
| 0.0 | 1.5 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 0.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.0 | 0.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.0 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.0 | 2.9 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 2.1 | GO:0044309 | neuron spine(GO:0044309) |
| 0.0 | 1.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 0.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.0 | 6.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.0 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.0 | 1.5 | GO:0070161 | anchoring junction(GO:0070161) |
| 0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 38.7 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.0 | 5.3 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
| 0.0 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 0.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.0 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
| 0.0 | 0.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.3 | GO:0070187 | telosome(GO:0070187) |
| 0.0 | 0.4 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
| 0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.0 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 10.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 0.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.0 | 4.2 | GO:0030424 | axon(GO:0030424) |
| 0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
| 0.0 | 0.0 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.0 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 0.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 0.1 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
| 0.0 | 2.3 | GO:0000922 | spindle pole(GO:0000922) |
| 0.0 | 0.0 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.0 | 0.3 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.0 | 0.1 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.0 | 1.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.0 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.0 | 0.6 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.0 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.0 | 3.0 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 2.0 | 6.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 1.7 | 11.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 1.7 | 5.0 | GO:0032428 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 1.6 | 4.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 1.6 | 6.3 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 1.5 | 7.5 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 1.4 | 4.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 1.4 | 8.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 1.3 | 6.3 | GO:0030395 | lactose binding(GO:0030395) |
| 1.2 | 6.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 1.2 | 3.7 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 1.2 | 8.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 1.2 | 5.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 1.1 | 6.8 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 1.1 | 15.6 | GO:0031014 | troponin T binding(GO:0031014) |
| 1.0 | 3.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 1.0 | 3.1 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 1.0 | 4.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 1.0 | 5.0 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 1.0 | 18.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 1.0 | 4.9 | GO:0032810 | sterol response element binding(GO:0032810) |
| 1.0 | 2.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.9 | 10.4 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.9 | 3.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.9 | 7.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.9 | 9.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.9 | 2.6 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.8 | 5.9 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.8 | 3.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.8 | 1.6 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.8 | 9.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.7 | 2.2 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.7 | 3.6 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.7 | 2.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.7 | 2.9 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.7 | 4.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.7 | 7.2 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.7 | 3.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.7 | 7.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.7 | 3.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.7 | 5.3 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.6 | 1.9 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
| 0.6 | 1.9 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.6 | 1.9 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.6 | 3.2 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.6 | 9.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.6 | 6.9 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.6 | 11.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.6 | 9.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.6 | 1.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.6 | 7.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.6 | 4.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.6 | 1.8 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 0.6 | 1.8 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.6 | 3.5 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 0.6 | 2.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.6 | 2.3 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.6 | 4.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.6 | 2.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.6 | 10.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.6 | 1.7 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.6 | 2.3 | GO:0070404 | NADH binding(GO:0070404) |
| 0.6 | 0.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
| 0.6 | 2.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.6 | 1.7 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.5 | 1.1 | GO:0070905 | serine binding(GO:0070905) |
| 0.5 | 3.3 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.5 | 2.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.5 | 1.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.5 | 1.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.5 | 3.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.5 | 2.6 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.5 | 3.1 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.5 | 2.0 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.5 | 1.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.5 | 3.6 | GO:0005497 | androgen binding(GO:0005497) |
| 0.5 | 3.0 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.5 | 2.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.5 | 0.5 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
| 0.5 | 1.5 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.5 | 2.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.5 | 10.4 | GO:0019841 | retinol binding(GO:0019841) |
| 0.5 | 3.0 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.5 | 1.5 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.5 | 7.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.5 | 1.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.5 | 1.5 | GO:0044714 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
| 0.5 | 7.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.5 | 5.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.5 | 2.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.5 | 3.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.5 | 1.4 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.5 | 2.9 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 0.5 | 1.4 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.5 | 1.4 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
| 0.5 | 1.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.5 | 8.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.5 | 1.4 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.5 | 2.8 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.5 | 1.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.5 | 4.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.5 | 1.4 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.4 | 2.6 | GO:0052848 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.4 | 2.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 0.4 | 5.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.4 | 0.4 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 0.4 | 1.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.4 | 8.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.4 | 2.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.4 | 1.3 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.4 | 1.3 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.4 | 4.2 | GO:0089720 | caspase binding(GO:0089720) |
| 0.4 | 6.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.4 | 1.3 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 0.4 | 1.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.4 | 13.7 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.4 | 1.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.4 | 1.7 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.4 | 1.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.4 | 26.4 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.4 | 1.7 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.4 | 3.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.4 | 2.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.4 | 1.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.4 | 1.2 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.4 | 3.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.4 | 4.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.4 | 1.2 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 0.4 | 127.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.4 | 4.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.4 | 1.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.4 | 5.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.4 | 1.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.4 | 2.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.4 | 1.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.4 | 1.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.4 | 1.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 0.4 | 6.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.4 | 1.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.4 | 2.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.4 | 1.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.4 | 4.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.4 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.4 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.4 | 1.5 | GO:0002046 | opsin binding(GO:0002046) |
| 0.4 | 1.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.4 | 1.1 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.4 | 2.9 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.4 | 3.3 | GO:0043426 | MRF binding(GO:0043426) |
| 0.4 | 4.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.4 | 2.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.4 | 1.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.4 | 13.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.4 | 1.8 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.4 | 5.3 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.4 | 1.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.3 | 2.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.3 | 1.7 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.3 | 1.0 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
| 0.3 | 1.7 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.3 | 5.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.3 | 2.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.3 | 4.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.3 | 2.0 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.3 | 1.3 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
| 0.3 | 1.0 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.3 | 1.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.3 | 30.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.3 | 1.3 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.3 | 1.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.3 | 1.6 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.3 | 2.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.3 | 1.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.3 | 2.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.3 | 3.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.3 | 0.3 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.3 | 9.0 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.3 | 6.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.3 | 1.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.3 | 1.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.3 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.3 | 0.9 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
| 0.3 | 0.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.3 | 2.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.3 | 1.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.3 | 1.3 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 0.3 | 0.9 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.3 | 6.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.3 | 0.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.3 | 1.6 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.3 | 2.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.3 | 4.7 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.3 | 7.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.3 | 3.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.3 | 0.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.3 | 6.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.3 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.3 | 1.8 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.3 | 2.1 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
| 0.3 | 0.9 | GO:0033265 | choline binding(GO:0033265) |
| 0.3 | 1.2 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 0.3 | 1.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.3 | 2.6 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.3 | 3.8 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.3 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.3 | 1.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.3 | 0.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.3 | 0.9 | GO:0035473 | lipase binding(GO:0035473) |
| 0.3 | 1.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.3 | 1.7 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.3 | 2.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.3 | 2.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.3 | 1.1 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.3 | 1.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.3 | 0.6 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.3 | 2.8 | GO:0034618 | arginine binding(GO:0034618) |
| 0.3 | 0.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.3 | 3.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.3 | 0.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.3 | 1.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.3 | 0.8 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 0.3 | 1.7 | GO:0071253 | connexin binding(GO:0071253) |
| 0.3 | 1.7 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.3 | 2.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.3 | 1.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.3 | 0.6 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.3 | 1.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.3 | 4.7 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.3 | 0.5 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.3 | 1.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.3 | 0.8 | GO:0004639 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 0.3 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.3 | 1.9 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.3 | 0.8 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.3 | 10.8 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.3 | 1.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.3 | 1.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.3 | 1.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.3 | 0.8 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.3 | 1.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.3 | 1.1 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.3 | 0.8 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.3 | 4.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.3 | 0.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.3 | 5.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.3 | 0.8 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.3 | 1.3 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.3 | 0.8 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.3 | 1.8 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.3 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
| 0.3 | 1.0 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.3 | 0.3 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.3 | 1.8 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.3 | 1.5 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.3 | 1.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.3 | 5.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.3 | 1.0 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.2 | 3.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 0.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.2 | 8.5 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.2 | 5.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.2 | 0.7 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.2 | 3.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 1.2 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.2 | 0.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.2 | 0.7 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 0.2 | 2.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.2 | 1.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.2 | 1.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.2 | 1.0 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.2 | 1.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.2 | 2.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.2 | 0.7 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.2 | 1.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.2 | 3.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 2.8 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.2 | 4.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.2 | 0.9 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.2 | 0.2 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 0.2 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.2 | 1.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 2.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.2 | 0.9 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.2 | 0.5 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.2 | 1.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.2 | 1.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.2 | 2.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.2 | 2.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.2 | 0.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.2 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.2 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.2 | 0.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.2 | 1.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.2 | 2.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.2 | 2.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.2 | 1.3 | GO:0005536 | glucose binding(GO:0005536) |
| 0.2 | 2.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.2 | 1.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.2 | 1.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.2 | 1.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.2 | 1.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.2 | 1.9 | GO:0031628 | opioid receptor binding(GO:0031628) |
| 0.2 | 2.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.2 | 14.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.2 | 6.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 2.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.2 | 3.2 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.2 | 0.6 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.2 | 2.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.2 | 0.6 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 0.2 | 1.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.2 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.2 | 0.4 | GO:0000035 | acyl binding(GO:0000035) |
| 0.2 | 0.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.2 | 0.6 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.2 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.2 | 0.6 | GO:0035375 | zymogen binding(GO:0035375) |
| 0.2 | 0.6 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.2 | 0.6 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.2 | 0.8 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.2 | 2.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
| 0.2 | 0.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.2 | 1.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.2 | 1.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 0.6 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
| 0.2 | 2.0 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.2 | 1.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.2 | 0.6 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.2 | 4.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 1.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 1.8 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.2 | 0.6 | GO:0052816 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
| 0.2 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.2 | 1.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.2 | 0.6 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
| 0.2 | 0.2 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.2 | 0.6 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.2 | 1.4 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.2 | 1.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.2 | 1.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.2 | 1.5 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.2 | 4.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 12.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.2 | 1.9 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
| 0.2 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.2 | 1.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.2 | 1.1 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.2 | 1.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.2 | 2.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.2 | 1.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 1.7 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.2 | 0.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.2 | 1.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.2 | 1.5 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.2 | 2.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.2 | 0.7 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.2 | 1.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.2 | 1.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.2 | 1.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.2 | 0.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.2 | 0.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.2 | 0.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.2 | 2.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.2 | 1.3 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.2 | 0.5 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
| 0.2 | 1.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.2 | 0.7 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.2 | 3.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.2 | 1.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 7.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.2 | 5.0 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 1.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.2 | 7.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.2 | 12.1 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.2 | 1.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.2 | 4.1 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.2 | 0.5 | GO:0033749 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 0.2 | 5.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 0.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.2 | 2.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.2 | 1.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.2 | 5.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 1.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.2 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.2 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.2 | 0.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.2 | 0.3 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
| 0.2 | 0.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.2 | 3.2 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 0.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.2 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.2 | 9.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.2 | 0.7 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.2 | 0.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.2 | 2.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.2 | 6.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 2.9 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 0.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.2 | 2.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.2 | 0.5 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.2 | 1.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.2 | 0.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.2 | 2.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 4.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.2 | 1.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.2 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.2 | 12.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.2 | 0.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.2 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.2 | 0.6 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.2 | 0.5 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.2 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.2 | 0.6 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.2 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.2 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.2 | 1.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.2 | 1.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.2 | 0.8 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.2 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 1.6 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.2 | 0.8 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.2 | 2.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 20.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.2 | 1.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.2 | 2.0 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.2 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.2 | 0.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.2 | 30.6 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.2 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.2 | 3.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 6.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.2 | 0.9 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.2 | 0.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.2 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.2 | 13.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.2 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.2 | 0.6 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
| 0.2 | 1.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 2.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.2 | 1.4 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.2 | 1.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 1.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.1 | 5.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.1 | 2.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 0.7 | GO:0034191 | apolipoprotein receptor binding(GO:0034190) apolipoprotein A-I receptor binding(GO:0034191) |
| 0.1 | 0.7 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.1 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 1.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 0.3 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
| 0.1 | 0.6 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.1 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.1 | 0.4 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.1 | 2.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 2.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 1.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.1 | 0.8 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.1 | 2.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.1 | 0.4 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
| 0.1 | 0.3 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
| 0.1 | 0.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.1 | 0.6 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.1 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.1 | 0.8 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.1 | 0.4 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 0.1 | 22.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 2.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 0.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 2.4 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 2.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 0.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.1 | 1.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 0.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.1 | 4.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.1 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.1 | 4.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 2.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.1 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.1 | 1.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 1.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.1 | 0.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.1 | 0.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.7 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.1 | 0.5 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.1 | 0.3 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 0.1 | 1.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 0.5 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.1 | 0.4 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
| 0.1 | 7.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.1 | 0.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.1 | 0.5 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 1.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.1 | 1.0 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.1 | 2.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.1 | 1.0 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.1 | 1.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 1.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 0.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.1 | 1.5 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 1.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.1 | 0.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.8 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.1 | 2.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 5.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 1.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.1 | 1.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.1 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 8.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.1 | 3.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.1 | 1.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.1 | 14.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 2.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 1.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.1 | 0.1 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.1 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 1.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 2.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 1.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 0.6 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.1 | 0.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 2.0 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.1 | 2.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 10.3 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 4.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.1 | 43.9 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 0.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.1 | 3.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.1 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.1 | 1.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 2.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 1.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 0.4 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.1 | 17.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.1 | 0.3 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.1 | 2.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 1.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 0.1 | 5.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 0.2 | GO:0016295 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
| 0.1 | 0.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.1 | 0.2 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.1 | 1.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 1.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 0.6 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.1 | 0.7 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.3 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 0.1 | 1.0 | GO:0035240 | dopamine binding(GO:0035240) |
| 0.1 | 5.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.1 | 0.5 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.1 | 1.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 2.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.1 | 3.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 1.8 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 1.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 0.3 | GO:0015203 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
| 0.1 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 3.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 0.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.1 | 2.9 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 3.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 2.9 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 0.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.1 | 0.4 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 0.4 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.1 | 0.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.1 | 0.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.4 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) fatty acid peroxidase activity(GO:0047888) |
| 0.1 | 0.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.1 | 1.4 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 0.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 0.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 1.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 1.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
| 0.1 | 2.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.1 | 0.3 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 0.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.1 | 2.3 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.1 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 1.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 0.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
| 0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 3.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 1.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.1 | 0.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.1 | 1.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 1.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 0.7 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.1 | 2.3 | GO:0005549 | odorant binding(GO:0005549) |
| 0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 2.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 2.3 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.1 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 2.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.1 | 1.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.1 | 0.1 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) azole transmembrane transporter activity(GO:1901474) |
| 0.1 | 1.7 | GO:0070008 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.1 | 0.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.1 | 6.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.1 | 0.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 0.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 1.7 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 0.4 | GO:0042835 | BRE binding(GO:0042835) |
| 0.1 | 0.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 3.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 0.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.1 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.1 | 0.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 2.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 28.9 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.1 | 0.3 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.1 | 0.2 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.1 | 0.6 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.1 | 0.3 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 0.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.1 | 0.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 0.3 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.1 | 0.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.1 | 0.4 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.1 | 2.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
| 0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 0.1 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.7 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.1 | 0.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.1 | 0.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 0.2 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.1 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.1 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 1.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 0.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.1 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.1 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 1.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 0.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 0.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.1 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.1 | 1.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 6.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.1 | 1.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 1.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 2.4 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 1.1 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 2.1 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 0.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.1 | 0.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.1 | 0.6 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.0 | 1.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.0 | 7.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.1 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.0 | 1.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.0 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 0.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.0 | 0.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.0 | 0.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.0 | 4.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.0 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.0 | 0.2 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.0 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.0 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.0 | 0.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.0 | 0.3 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.0 | 0.4 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.0 | 0.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.0 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.0 | 0.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.0 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.0 | 0.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.0 | 1.5 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.0 | 2.4 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.0 | 3.1 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.1 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 0.0 | 2.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 4.4 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.0 | 0.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.0 | 1.5 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 1.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.0 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.0 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.0 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.0 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.0 | 1.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.0 | 0.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 0.2 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.0 | 0.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.2 | GO:0016248 | channel inhibitor activity(GO:0016248) |
| 0.0 | 0.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.0 | 0.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.0 | 1.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.0 | 5.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.1 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.0 | 1.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.0 | 1.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 1.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 0.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.0 | 0.1 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.0 | 1.2 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.0 | 1.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.2 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.1 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.0 | 0.1 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) L-glutamine aminotransferase activity(GO:0070548) |
| 0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.0 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.0 | 3.5 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.0 | 0.1 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.0 | 0.0 | GO:0070061 | fructose binding(GO:0070061) |
| 0.0 | 0.0 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
| 0.0 | 0.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.0 | 0.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.0 | 0.0 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.0 | 0.0 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.0 | 1.0 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.0 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 22.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.6 | 11.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.5 | 40.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.5 | 0.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.5 | 4.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.5 | 30.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.5 | 0.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.4 | 6.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.4 | 2.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.4 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.4 | 4.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.4 | 16.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.4 | 15.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.3 | 8.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.3 | 17.7 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.3 | 11.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.3 | 3.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.3 | 16.9 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.3 | 2.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.3 | 14.6 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.3 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.3 | 3.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.3 | 10.6 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.3 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.3 | 16.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 13.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 7.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 15.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.2 | 13.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.2 | 15.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.2 | 2.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.2 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.2 | 5.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.2 | 23.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.2 | 1.7 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.2 | 6.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 3.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.2 | 16.2 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.2 | 1.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 4.6 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 11.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.2 | 7.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.2 | 0.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.2 | 3.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.2 | 6.5 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.2 | 11.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.2 | 4.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.2 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.2 | 4.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 4.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 1.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.2 | 54.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.2 | 2.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.2 | 3.9 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.2 | 6.6 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.2 | 2.5 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.2 | 4.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 3.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.2 | 1.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.2 | 9.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 3.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 0.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 2.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 8.7 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 56.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 4.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 1.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 1.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 2.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 2.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 7.6 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 4.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 2.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 0.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 2.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 1.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.1 | 2.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 2.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 3.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 2.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 1.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 1.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 2.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 1.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 2.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 3.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 1.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 0.9 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.1 | 1.8 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.1 | 3.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 1.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 2.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.1 | 2.6 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 2.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 0.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 2.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 4.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 1.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.0 | 0.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 1.3 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.0 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 1.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 1.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 1.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 0.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 5.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 0.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 1.6 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.9 | 1.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.9 | 14.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.8 | 18.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.8 | 3.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.6 | 1.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.6 | 13.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.5 | 20.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.5 | 19.5 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.5 | 32.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.5 | 0.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.5 | 3.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.5 | 10.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.5 | 18.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.5 | 20.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.5 | 8.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.5 | 9.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.4 | 10.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 7.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.4 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.4 | 18.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.4 | 9.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.4 | 7.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.4 | 2.9 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.4 | 4.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.3 | 24.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.3 | 5.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.3 | 9.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.3 | 8.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.3 | 1.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.3 | 14.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.3 | 3.5 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 0.3 | 1.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.3 | 6.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.3 | 1.8 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
| 0.3 | 3.9 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.3 | 8.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.3 | 2.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.3 | 5.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.3 | 5.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.3 | 8.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.3 | 0.8 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.3 | 10.8 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.3 | 0.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.3 | 1.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.3 | 2.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.3 | 2.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.3 | 2.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.2 | 3.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.2 | 9.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 11.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.2 | 1.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.2 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.2 | 7.3 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
| 0.2 | 24.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 1.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.2 | 8.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.2 | 9.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 2.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 5.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.2 | 10.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 0.4 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
| 0.2 | 16.0 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.2 | 4.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.2 | 6.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.2 | 6.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 1.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.2 | 1.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.2 | 3.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 5.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 4.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 0.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.2 | 2.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 0.2 | 2.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.2 | 12.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.2 | 3.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.2 | 1.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.2 | 5.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.2 | 13.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.2 | 7.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.2 | 2.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 2.2 | REACTOME OPSINS | Genes involved in Opsins |
| 0.2 | 3.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 3.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.2 | 4.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 6.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.2 | 13.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.2 | 3.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 4.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.2 | 4.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.2 | 2.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.2 | 5.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.2 | 3.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.2 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.1 | 1.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 5.3 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
| 0.1 | 0.9 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.1 | 1.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 1.8 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.1 | 4.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.1 | 4.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 1.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.1 | 2.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.1 | 2.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.1 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 4.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 2.8 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 2.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 1.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 3.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.1 | 1.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 1.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 2.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 1.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.1 | 5.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 0.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 1.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.1 | 1.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 2.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 16.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.1 | 1.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 1.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 1.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 3.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 3.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 0.1 | 3.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.1 | 6.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 1.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 2.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
| 0.1 | 0.6 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.1 | 2.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.1 | 17.0 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.1 | 1.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 1.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 2.7 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 0.1 | 1.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 2.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 1.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.1 | 0.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 6.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 5.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.1 | 2.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 1.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 3.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 2.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 3.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 0.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 1.6 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
| 0.1 | 4.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 1.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.1 | 0.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.1 | 0.9 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
| 0.1 | 0.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 1.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.1 | 2.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.1 | 4.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 0.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 1.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 2.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 8.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 0.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 8.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.1 | 0.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 0.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.1 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 6.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 1.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 6.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 6.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.1 | 0.5 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.1 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 1.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.0 | 1.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 1.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.0 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.0 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.0 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.0 | 1.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 1.0 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.0 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 3.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.0 | 1.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 1.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.0 | 1.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.0 | 1.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 3.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.0 | 0.6 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
| 0.0 | 0.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.0 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 0.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.1 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 0.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
| 0.0 | 0.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 0.1 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |